CM8®: The Science Behind FlexPet

Clinically studied to reduce inflammation, improve mobility,
and support joint comfort — found only in FlexPet.

What Is CM8®?

CM8® stands for Cetyl Myristoleate — a naturally occurring fatty acid ester researched for its ability to reduce inflammation and improve joint function. It was first discovered in 1972 by Dr. Harry Diehl, a researcher at the National Institutes of Health. Dr. Diehl was awarded three U.S. patents for this discovery: Patent Nos. 4,049,824; 4,113,881; and 5,569,676. CM8 remains exclusive to the FlexPet formula.

Backed by Science.
Proven in Practice.

Lubricates joints naturally

Supports inflammation response

Exclusive to FlexPet

Clinical Study Results

Randomized, double-blind, placebo-controlled trial (n=382):

Placebo Group:

0 %

improvement

CM8 Group:

0 %

improvement

CM8 + Nutrients:

0 %

improvement

Results based on self-assessments, clinical evaluation, lab & imaging.

Source: Siemandi H., Townsend Letter for Doctors and Patients, 1997

Clean, Clinical, and
Proven Safe

CM8 is distilled and crystallized to remove inert compounds.
Manufactured in the USA under strict GMP standards.